Thinking of joining a study?

Register your interest

NCT03346772 | RECRUITING | Influenza Vaccination


Study of Immune Responses to Influenza Vaccination
Sponsor:

University of Pennsylvania

Brief Summary:

Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.

Condition or disease

Influenza Vaccination

Intervention/treatment

Influenza vaccination

Phase

PHASE4

Study Type : INTERVENTIONAL
Estimated Enrollment : 75 participants
Masking : NONE
Primary Purpose : BASIC_SCIENCE
Official Title : Study of Immune Responses to Influenza Vaccination
Actual Study Start Date : 2017-10-20
Estimated Primary Completion Date : 2025-07-01
Estimated Study Completion Date : 2026-07-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * Community-dwelling adults able to provide consent who need influenza vaccination for standard of care
Exclusion Criteria
  • * febrile illness at time of vaccination
  • * active malignancy
  • * use of immunosuppressing medications
  • * blood donation in the past 60 days
  • * influenza vaccinated during the preceding 6 months
  • * allergic reactions to influenza vaccination

Study of Immune Responses to Influenza Vaccination

Location Details

NCT03346772


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Pennsylvania

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

Loading...